Bhubaneswar-based Biotech Startup Exsure raised ₹3 Cr in a seed round led by Unicorn India Ventures to reduce the toxicity of chemotherapy drugs.
PRIVATEJan 22, 2025
Amount Raised
₹30 Million
Round Type
Seed
BhubaneshwarBiotechnologyHealth CareMedical
Investors
Unicorn India Ventures
Description
Exsure, a startup focused on minimizing the toxicity of chemotherapy drugs, recently raised ₹3 Cr in a seed round led by Unicorn India Ventures. The company aims to empower cancer patients by providing targeted treatments and has started collaborating with distributors for global market expansion.
Who to call at Exsure, and when
A new round usually means Exsure is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Exsure raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Exsure, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Exsure. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Exsure
Location
Bhubaneshwar, Odisha, India
About
Exsure is a biotech startup founded by Swastika Paul and Abhishek Dutta in 2021, focused on reducing the side-effects and toxicity of anti-cancer drugs through its patented exosomal drug-delivery platform. The company aims to improve the overall survival and therapy outcomes of cancer patients. Exsure has launched its first in-house manufactured products and is actively seeking global market expansion. It aims to empower millions of cancer patients worldwide and enhance their quality of life.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Exsure raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BhubaneshwarBiotechnologyHealth CareMedical